73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
FDA approves new treatment for advanced melanoma

FDA approves new treatment for advanced melanoma

by Robin FosterThe U.S. Food and Drug Administration has approved a novel treatment for advanced melanoma, the most deadly form of skin cancer.Amtagvi, made by Iovance Biotherapeutics Inc., becomes th

FDA approves new treatment for advanced melanoma

by Robin FosterThe U.S. Food and Drug Administration has approved a novel treatment for advanced melanoma, the most deadly form of skin cancer.Amtagvi, made by Iovance Biotherapeutics Inc., becomes th
Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

by Roswell Park Comprehensive Cancer CenterAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainUp to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene

Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

by Roswell Park Comprehensive Cancer CenterAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainUp to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene
Salvia miltiorrhiza extract is a potential preventive agent for gastric cancer induced by bile reflux

Salvia miltiorrhiza extract is a potential preventive agent for gastric cancer induced by bile reflux

byHong Kong Baptist UniversityConjugated BAs were highly associated with bile reflux gastritis. Human gastric sections and juice are analyzed in control (n = 50), BRG (n = 50), and GC (n = 45) g

Salvia miltiorrhiza extract is a potential preventive agent for gastric cancer induced by bile reflux

byHong Kong Baptist UniversityConjugated BAs were highly associated with bile reflux gastritis. Human gastric sections and juice are analyzed in control (n = 50), BRG (n = 50), and GC (n = 45) g
Insurance disparities ID'd in diagnosis of late-stage melanoma

Insurance disparities ID'd in diagnosis of late-stage melanoma

For nonelderly adults in the United States, having Medicaid or no health insurance is associated with increased odds of being diagnosed with late-stage melanoma compared with having private insurance,

Insurance disparities ID'd in diagnosis of late-stage melanoma

For nonelderly adults in the United States, having Medicaid or no health insurance is associated with increased odds of being diagnosed with late-stage melanoma compared with having private insurance,
Novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors

Novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors

byVall d'Hebron Institute of OncologyGeneration and characterization of p95HER2.CART cells. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-53265-7One-third of

Novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors

byVall d'Hebron Institute of OncologyGeneration and characterization of p95HER2.CART cells. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-53265-7One-third of
Colon cancer is being spotted in younger people, and at later stages

Colon cancer is being spotted in younger people, and at later stages

by Steven ReinbergColon cancer continues to rise among younger U.S. adults, with the American Cancer Society reporting a doubling of cases in people younger than 55 in about 25 years.Also, significant

Colon cancer is being spotted in younger people, and at later stages

by Steven ReinbergColon cancer continues to rise among younger U.S. adults, with the American Cancer Society reporting a doubling of cases in people younger than 55 in about 25 years.Also, significant
Local radiotherapy improves survival in metastatic prostate cancer with low disease burden

Local radiotherapy improves survival in metastatic prostate cancer with low disease burden

byEuropean Society for Medical OncologyRadiotherapy to the prostate improves overall survival in men newly diagnosed with metastatic prostate cancer who have a low metastatic disease burden but

Local radiotherapy improves survival in metastatic prostate cancer with low disease burden

byEuropean Society for Medical OncologyRadiotherapy to the prostate improves overall survival in men newly diagnosed with metastatic prostate cancer who have a low metastatic disease burden but
Study finds novel molecular therapeutic target for colon cancer

Study finds novel molecular therapeutic target for colon cancer

byBoston University School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers have found a way to help make chemotherapy more effective in treating col

Study finds novel molecular therapeutic target for colon cancer

byBoston University School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers have found a way to help make chemotherapy more effective in treating col
Team of sister scientists identify a possible genetic culprit for uterine corpus endometrial cancer

Team of sister scientists identify a possible genetic culprit for uterine corpus endometrial cancer

by Allison Trouten,Medical University of South CarolinaMYO5B mRNA is elevated in uterine corpus endometrial carcinoma (UCEC) patients. A. The expression of MYO5B in various control tissues and t

Team of sister scientists identify a possible genetic culprit for uterine corpus endometrial cancer

by Allison Trouten,Medical University of South CarolinaMYO5B mRNA is elevated in uterine corpus endometrial carcinoma (UCEC) patients. A. The expression of MYO5B in various control tissues and t
Entering the golden age for antibody-drug conjugates in gynecologic cancer

Entering the golden age for antibody-drug conjugates in gynecologic cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn an editorial, published inOncosciencetitled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer,&quo

Entering the golden age for antibody-drug conjugates in gynecologic cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn an editorial, published inOncosciencetitled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer,&quo
Drug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy

Drug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy

by Weill Cornell Medical CollegeMycobacterium tuberculosis. Credit: United States Centers for Disease Control and PreventionPatients who have drug-resistant tuberculosis (TB) have a similar micro

Drug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy

by Weill Cornell Medical CollegeMycobacterium tuberculosis. Credit: United States Centers for Disease Control and PreventionPatients who have drug-resistant tuberculosis (TB) have a similar micro